IDEAYA Biosciences, Inc. Income Statement

Income Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 19.54M27.94M50.93M23.39M7.00M
Gross Profit 19.54M27.94M50.93M23.39M7.00M
Operating items
Research & Development 34.32M39.70M58.16M89.54M129.51M294.67M
Selling, General & Administrative 9.95M15.18M20.05M23.90M28.31M39.30M
Operating Expenses 44.27M54.88M78.21M113.43M157.81M333.98M
Operating Income -44.27M-35.34M-50.27M-62.50M-134.43M-326.98M
EBIT -44.27M-35.34M-50.27M-62.50M-134.43M-326.98M
Non-operating items
Non Operating Income 2.30M0.85M0.51M3.85M21.47M52.50M
Net income details
EBT -44.27M-35.34M-50.27M-62.50M-134.43M-326.98M
Profit After Tax -41.98M-34.49M-49.76M-58.66M-112.96M-274.48M
Income from Continuing Operations -44.27M-35.34M-50.27M-62.50M-134.43M-326.98M
Consolidated Net Income -44.27M-35.34M-50.27M-62.50M-134.43M-326.98M
Income towards Parent Company -44.27M-35.34M-50.27M-62.50M-134.43M-326.98M
Net Income towards Common Stockholders -44.27M-35.34M-50.27M-62.50M-134.43M-326.98M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 20.33M29.07M38.50M48.11M64.46M86.43M
Shares Outstanding (Diluted Average) 35.25M41.44M57.52M81.68M
EBITDA -41.88M-34.55M-50.48M-60.81M-109.53M-274.23M